Clinical trial
Thoratec HeartMate II Left Ventricular Assist System (LVAS) for Destination…
NCT00121485 · Abbott Medical Devices, Industry · Completed
Key facts
| NCT number | NCT00121485 |
|---|---|
| Title | Thoratec HeartMate II Left Ventricular Assist System (LVAS) for Destination Therapy |
| Official title | The HeartMate II LVAS Pivotal Study Protocol, Destination Therapy |
| Lead sponsor | Abbott Medical Devices, Industry |
| Collaborators | Thoratec Corporation Industry |
| Status | Completed |
| Study type | Interventional |
| Conditions | Heart Failure, Congestive, Ventricular Dysfunction, Cardiomyopathies |
| Intervention type | Device |
| Interventions | Left Ventricular Assist System (LVAS) |
| Enrollment | 200 |
| Start date | Feb 1, 2005 |
| Primary completion | Jun 1, 2009 |
| Completion | Jan 1, 2012 |
| First posted | Jul 21, 2005 |
| Last update posted | Jun 27, 2022 |
| Countries | Canada, United States |
At a glance
- 10–99 Study sites
- Yes Results posted
- 1–9 Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: